| Gut microbiota and obesity: a role for probiotics L Abenavoli, E Scarpellini, C Colica, L Boccuto, B Salehi, J Sharifi-Rad, ... Nutrients 11 (11), 2690, 2019 | 480 | 2019 |
| Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease F Borrelli, I Fasolino, B Romano, R Capasso, F Maiello, D Coppola, ... Biochemical pharmacology 85 (9), 1306-1316, 2013 | 351 | 2013 |
| Novel insights into the pharmacology of flavonoids B Romano, E Pagano, V Montanaro, AL Fortunato, N Milic, F Borrelli Phytotherapy research 27 (11), 1588-1596, 2013 | 286 | 2013 |
| Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid F Borrelli, E Pagano, B Romano, S Panzera, F Maiello, D Coppola, ... Carcinogenesis 35 (12), 2787-2797, 2014 | 247 | 2014 |
| Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer G Aviello, B Romano, F Borrelli, R Capasso, L Gallo, F Piscitelli, ... Journal of molecular medicine 90, 925-934, 2012 | 242 | 2012 |
| Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism TDM Hill, MG Cascio, B Romano, M Duncan, RG Pertwee, CM Williams, ... British journal of pharmacology 170 (3), 679-692, 2013 | 233 | 2013 |
| Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis F Borrelli, G Aviello, B Romano, P Orlando, R Capasso, F Maiello, ... Journal of molecular medicine 87, 1111-1121, 2009 | 220 | 2009 |
| The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis B Romano, F Borrelli, I Fasolino, R Capasso, F Piscitelli, MG Cascio, ... British journal of pharmacology 169 (1), 213-229, 2013 | 187 | 2013 |
| Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti‐inflammatory agent F Borrelli, B Romano, S Petrosino, E Pagano, R Capasso, D Coppola, ... British journal of pharmacology 172 (1), 142-158, 2015 | 180 | 2015 |
| Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re‐feeding AA Izzo, F Piscitelli, R Capasso, G Aviello, B Romano, F Borrelli, ... British journal of pharmacology 158 (2), 451-461, 2009 | 180 | 2009 |
| Inhibitory effect of cannabichromene, a major non‐psychotropic cannabinoid extracted from Cannabis sativa, on inflammation‐induced hypermotility in mice AA Izzo, R Capasso, G Aviello, F Borrelli, B Romano, F Piscitelli, L Gallo, ... British journal of pharmacology 166 (4), 1444-1460, 2012 | 177 | 2012 |
| Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice R Capasso, F Borrelli, G Aviello, B Romano, C Scalisi, F Capasso, ... British journal of pharmacology 154 (5), 1001-1008, 2008 | 156 | 2008 |
| Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol B Romano, F Borrelli, E Pagano, MG Cascio, RG Pertwee, AA Izzo Phytomedicine 21 (5), 631-639, 2014 | 153 | 2014 |
| An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse E Pagano, R Capasso, F Piscitelli, B Romano, OA Parisi, S Finizio, ... Frontiers in pharmacology 7, 341, 2016 | 131 | 2016 |
| Garlic: empiricism or science? G Aviello, L Abenavoli, F Borrelli, R Capasso, AA Izzo, F Lembo, ... Natural Product Communications 4 (12), 1934578X0900401231, 2009 | 114 | 2009 |
| Antisense oligonucleotide: basic concepts and therapeutic application in inflammatory bowel disease D Di Fusco, V Dinallo, I Marafini, MM Figliuzzi, B Romano, G Monteleone Frontiers in pharmacology 10, 440751, 2019 | 110 | 2019 |
| The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high‐fat diet V Di Marzo, R Capasso, I Matias, G Aviello, S Petrosino, F Borrelli, ... British Journal of Pharmacology 153 (6), 1272-1280, 2008 | 109 | 2008 |
| Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis‐induced hypermotility: cross‐talk between κ‐opioid and cannabinoid CB1 receptors R Capasso, F Borrelli, MG Cascio, G Aviello, K Huben, JK Zjawiony, ... British journal of pharmacology 155 (5), 681-689, 2008 | 98 | 2008 |
| Cannabinoids and gastrointestinal motility: animal and human studies. G Aviello, B Romano, AA Izzo European Review for Medical & Pharmacological Sciences 12, 2008 | 94 | 2008 |
| Pharmacological insights and prediction of lead bioactive isolates of Dita bark through experimental and computer-aided mechanism MF Khan, FB Kader, M Arman, S Ahmed, C Lyzu, SA Sakib, SM Tanzil, ... Biomedicine & Pharmacotherapy 131, 110774, 2020 | 92 | 2020 |
